| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/14656566.2017.1316369 |
| P698 | PubMed publication ID | 28398096 |
| P50 | author | Christian Höcht | Q105667420 |
| P2093 | author name string | Diego A Chiappetta | |
| Marcela A Moretton | |||
| Eduardo Lagomarsino | |||
| Facundo Bertera | |||
| Jennifer Riedel | |||
| P2860 | cites work | Management of HIV Infection during Pregnancy in the United States: Updated Evidence-Based Recommendations and Future Potential Practices | Q26738453 |
| Antiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan Africa | Q27014960 | ||
| HIV-free survival at 12-24 months in breastfed infants of HIV-infected women on antiretroviral treatment | Q28070420 | ||
| Mother and child both matter: reconceptualizing the prevention of mother-to-child transmission care continuum | Q28082436 | ||
| Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission | Q30569674 | ||
| Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi | Q33563656 | ||
| Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial | Q33863552 | ||
| Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis | Q34355499 | ||
| Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy | Q34387805 | ||
| Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis. | Q34420923 | ||
| Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial | Q34634644 | ||
| Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi | Q35452458 | ||
| Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women | Q35597592 | ||
| Risk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting? | Q35691443 | ||
| Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission | Q36201097 | ||
| Maternal or infant antiretroviral drugs to reduce HIV-1 transmission | Q36231035 | ||
| Maternal Tenofovir Disoproxil Fumarate Use in Pregnancy and Growth Outcomes among HIV-Exposed Uninfected Infants in Kenya | Q36448494 | ||
| Three postpartum antiretroviral regimens to prevent intrapartum HIV infection | Q36662110 | ||
| Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes | Q36852619 | ||
| Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel | Q37234729 | ||
| Long-acting injectable antiretrovirals for HIV treatment and prevention | Q37272776 | ||
| Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis | Q37335159 | ||
| Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention | Q37558394 | ||
| HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana | Q37703445 | ||
| Antiretroviral drugs to prevent breastfeeding HIV transmission | Q37768599 | ||
| HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1. | Q38027770 | ||
| Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option B+ approach | Q38127321 | ||
| Long-acting antiviral agents for HIV treatment | Q38518438 | ||
| Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates. | Q38551995 | ||
| Challenges in the Elimination of Pediatric HIV-1 Infection | Q38757697 | ||
| Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial | Q38856767 | ||
| Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial | Q38967453 | ||
| HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa. | Q39648148 | ||
| Improving HIV pre-exposure prophylaxis for infants | Q40896394 | ||
| Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study | Q43281055 | ||
| Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial | Q45405108 | ||
| Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis | Q56092169 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prevention of HIV/AIDS | Q7242372 |
| HIV transmission | Q49029021 | ||
| P304 | page(s) | 657-666 | |
| P577 | publication date | 2017-04-11 | |
| P1433 | published in | Expert Opinion on Pharmacotherapy | Q5421212 |
| P1476 | title | Advances in therapy for the prevention of HIV transmission from mother to child | |
| P478 | volume | 18 |
Search more.